Salta alla navigazione principale Salta alla ricerca Salta al contenuto principale

Dual block with lapatinib and trastuzumab versus single-agent trastuzumab combined with chemotherapy as neoadjuvant treatment of HER2-positive breast cancer: A meta-analysis of randomized trials

  • Matteo Clavarezza
  • , Matteo Puntoni
  • , Alessandra Gennari
  • , Laura Paleari
  • , Nicoletta Provinciali
  • , Mauro D'Amico
  • , Andrea DeCensi

Risultato della ricerca: Contributo su rivista › Articolo in rivista › peer review

Fingerprint

Entra nei temi di ricerca di 'Dual block with lapatinib and trastuzumab versus single-agent trastuzumab combined with chemotherapy as neoadjuvant treatment of HER2-positive breast cancer: A meta-analysis of randomized trials'. Insieme formano una fingerprint unica.
Ordina per

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science